RightFit
Not yet recruitingNot applicable

Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Participants will also complete study surveys and logs."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether an artificial intelligence (AI) tool can help patients understand information after their first cancer care visit. It looks at whether the tool is practical to use, whether patients accept it, and its early effects. It is for adults newly diagnosed with prostate cancer that has not spread who are having or recently had a radiation or surgery care visit at UCSF.

A randomized, open-label behavioral study designed to evaluate the feasibility, acceptability, and early impact of a large language model (LLM)-based artificial intelligence (AI) tool to support patient understanding following an initial oncology consultation.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • You are age 18 or older.
  • Tests of tissue or cells show prostate cancer that has not spread.
  • You are newly diagnosed and plan to have, or recently had, a radiation or surgery care visit at the University of California, San Francisco (UCSF).
  • You can care for yourself and are out of bed or a chair for more than half of your waking hours (ECOG score 0–2).
  • You speak English and can take part in study calls.
  • You can understand the study and are willing to sign a form agreeing to join.
  • You have a device and internet connection that let you join study calls.

Who can't join

  • You have already had treatment meant to treat your prostate cancer, such as surgery, radiation, or medicine that works throughout the body.
  • Problems with thinking, sight, hearing, or language would keep you from understanding or completing study tasks.
  • You cannot or do not want to join two study calls.
  • You are in another study that tests a treatment or other approach and may interfere with this study.
  • You cannot follow study rules, such as filling out surveys or using the information-tracking log.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: 1. Age ≥18 years. 2. Histologically or cytologically confirmed diagnosis of localized prostate cancer 3. Newly diagnosed and planning to undergo or recently completed a radiation or surgical oncology consult at University of California, San Francisco (UCSF) 4. Eastern Cooperative Oncology Group (ECOG) performance status of 0-2 5. English-speaking and able to participate in study teleconferences 6. Ability to understand and willingness to sign a written informed consent document 7. Access to a device and internet connection sufficient for teleconference participation Exclusion Criteria: 1. Prior definitive treatment for prostate cancer (e.g., surgery, radiation, or systemic therapy) 2. Cognitive, sensory, or language impairment that would interfere with the ability to understand, participate in, or complete the study procedures 3. Inability or unwillingness to participate in two study-related teleconferences 4. Current enrollment in another interventional clinical trial that may interfere with study participation 5. Inability to comply with protocol requirements (e.g., completing surveys or using the information-tracking log)

Study sites (1)

CA